MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-04-2025
Nevro Corp. Market Cap 2011-2026 | NVRO
As of April 29, 2026 Nevro Corp. has a market cap of $ 217 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Nevro Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 213 M | 544 M | 1.2 B | 2.29 B | 5.45 B | 4.19 B | 1.47 B | 2.36 B | 2.43 B | 1.64 B | 202 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.45 B | 202 M | 2 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 13.38 | 2.29 % | $ 1.81 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.28 | 1.86 % | $ 123 M |  France |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.6 | -1.96 % | $ 37.3 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 11.08 | -1.16 % | $ 314 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
175 M | $ 25.74 | -1.0 % | $ 218 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 90.74 | -3.16 % | $ 12.3 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.08 | -1.89 % | $ 1.26 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 5.16 | -5.84 % | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.14 | -4.3 % | $ 355 M | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.55 | -2.68 % | $ 378 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.04 | -3.7 % | $ 17.6 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.79 | -2.85 % | $ 1.14 B | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 61.29 | -3.34 % | $ 3.34 B |  Britain |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 55.11 | 0.07 % | $ 1.62 B | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.35 | 2.69 % | $ 64 M | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 84.64 | -0.83 % | $ 2.94 B | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.23 | -4.3 % | $ 50 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 82.28 | -1.41 % | $ 48.1 B | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 3.4 | 1.8 % | $ 502 M | USA |
 |
NanoVibronix
NAOV
|
92 K | - | - | $ 1.08 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.82 | -1.19 % | $ 34.3 M | USA |
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
Natus Medical Incorporated
NTUS
|
799 M | - | 1.94 % | $ 1.05 B | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 11.91 | -3.33 % | $ 472 M |  Curacao |